The estimated Net Worth of Jean Luc Butel is at least $346 millier dollars as of 16 February 2021. Mr. Butel owns over 1,225 units of Varian Medical Systems stock worth over $73,002 and over the last 13 years he sold VAR stock worth over $0. In addition, he makes $272,621 as Independent Director at Varian Medical Systems.
Sign up
Mr. Butel VAR stock SEC Form 4 insiders trading
Jean has made over 4 trades of the Varian Medical Systems stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 1,225 units of VAR stock worth $20,255 on 16 February 2021.
The largest trade he's ever made was exercising 1,871 units of Varian Medical Systems stock on 2 March 2020 worth over $30,937. On average, Jean trades about 340 units every 43 days since 2012. As of 16 February 2021 he still owns at least 4,415 units of Varian Medical Systems stock.
You can see the complete history of Mr. Butel stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Jean-Luc Butel biography
Jean-Luc Butel serves as Independent Director of the Company. ?Positions at Baxter International, a health care company providing a portfolio of renal and hospital products: • ?President, International (January 2015—June 2015) • ?Corporate Officer, Operating Committee Member, Corporate Vice President and President, International (February 2012—December 2014) • ?Positions at Medtronic, Inc., a global leader in medical technology: • ?Corporate Officer, Executive Committee Member, Executive Vice President; Group President International (January 2011—January 2012) • ?Corporate Officer, Executive Committee Member, Senior Vice President and President, Medtronic International (May 2008—December 2010) • ?Corporate Officer, Executive Committee Member, Senior Vice President, Medtronic and President, Medtronic Asia Pacific (August 2003—April 2008) • ?Other Senior Management Experience: President, Johnson & Johnson Independence Technology; President, Worldwide Consumer Healthcare, Becton Dickinson • ?Other Current Public Company Board Memberships: Takeda Pharmaceutical Company Limited, a global pharmaceuticals company focused on metabolic disorders, gastroenterology, neurology, inflammation and oncology • ?Prior Public Company Board Memberships in Past Five Years: Biosensors International Group, Ltd., a medical device company specializing in interventional cardiology procedures and critical care technologies.
What is the salary of Jean Butel?
As the Independent Director of Varian Medical Systems, the total compensation of Jean Butel at Varian Medical Systems is $272,621. There are 7 executives at Varian Medical Systems getting paid more, with Dow Wilson having the highest compensation of $9,446,300.
How old is Jean Butel?
Jean Butel is 63, he's been the Independent Director of Varian Medical Systems since 2017. There are 2 older and 11 younger executives at Varian Medical Systems. The oldest executive at Varian Medical Systems, Inc. is David Illingworth, 66, who is the Independent Director.
What's Jean Butel's mailing address?
Jean's mailing address filed with the SEC is C/O VARIAN MEDICAL SYSTEMS, INC., 3100 HANSEN WAY, MAIL STOP E-327, PALO ALTO, CA, 94304-1030.
Insiders trading at Varian Medical Systems
Over the last 22 years, insiders at Varian Medical Systems have traded over $57,574,967 worth of Varian Medical Systems stock and bought 500 units worth $22,595 . The most active insiders traders include Kent J Thiry, Timothy E Guertin et Dow R Wilson. On average, Varian Medical Systems executives and independent directors trade stock every 11 days with the average trade being worth of $181,124. The most recent stock trade was executed by Jesse Michael Bruff on 1 March 2021, trading 6,499 units of VAR stock currently worth $1,142,589.
What does Varian Medical Systems's logo look like?
Complete history of Mr. Butel stock trades at Baxter International et Varian Medical Systems
Varian Medical Systems executives and stock owners
Varian Medical Systems executives and other stock owners filed with the SEC include:
-
Dow Wilson,
Chief Executive Officer, Director -
Kolleen Kennedy,
President - Proton Solutions Division and Chief Growth Officer -
Chris Toth,
President, Chief Operating Officer -
R. Andrew Eckert,
Independent Chairman of the Board -
Jeffrey Balser,
Independent Director -
Judy Bruner,
Independent Director -
Anat Ashkenazi,
Independent Director -
Jean-Luc Butel,
Independent Director -
Regina Dugan,
Independent Director -
David Illingworth,
Independent Director -
Phillip Febbo,
Independent Director -
Michael Hutchinson,
Senior Vice President, Chief Legal Officer -
Francis Facchini,
President, Interventional Solutions Business -
Anshul Maheshwari,
Vice President, Treasurer and Investor Relations -
Michelle Le Beau,
Independent Director -
J. Michael Bruff,
Chief Financial Officer, Senior Vice President - Finance -
Magnus Momsen,
SVP, CAO, Corporate Controller -
Mark R Laret,
Director -
Jose Baselga,
Director -
John W Kuo,
SVP, Gen Counsel and Secretary -
Gary E Jr Bischoping,
SVP, Finance & CFO -
Susan L Bostrom,
Director -
Timothy E Guertin,
Director -
Clarence R Verhoef,
SVP, Finance, Corp Controller -
Venkatraman Thyagarajan,
Director -
Sunny Sanyal,
SVP and President, ICB -
Robert H Kluge,
Corporate Vice President -
Richard M Levy,
President and CEO -
Ruediger Naumann Etienne,
Director -
John Seely Brown,
Director -
Erich R Reinhardt,
Director -
Tai Yun Chen,
VP and Corporate Controller -
David W Jr Martin,
Director -
Steven A Leibel,
Director -
Kent J Thiry,
Director -
Allen S Lichter,
Director -
Samuel Hellman,
Director -
Crisanto C Raimundo,
Corporate Controller -
Terry R Lautenbach,
Director -
Joseph B Phair,
VP Admin,Gen Counsel,Secretary -
Elisha W Finney,
Corporate Vice President & CFO -
Kevin O'reilly,
SVP, President of Oncology Sys